Zhang Q, Sun W, Zheng M, Zhang N
Front Microbiol. 2024; 15:1452390.
PMID: 39155988
PMC: 11327027.
DOI: 10.3389/fmicb.2024.1452390.
DePaula-Silva A
Viruses. 2024; 16(1).
PMID: 38257819
PMC: 10819099.
DOI: 10.3390/v16010119.
Srivastava P, Chaudhary S, Malhotra S, Varma B, Sunil S
Heliyon. 2023; 9(6):e17158.
PMID: 37408916
PMC: 10318463.
DOI: 10.1016/j.heliyon.2023.e17158.
Kim B
Front Immunol. 2023; 14:1167972.
PMID: 37153539
PMC: 10157096.
DOI: 10.3389/fimmu.2023.1167972.
Psenicka M, Smith B, Tinkey R, Williams J
Front Cell Neurosci. 2021; 15:654284.
PMID: 34234647
PMC: 8255483.
DOI: 10.3389/fncel.2021.654284.
Excessive Innate Immunity Steers Pathogenic Adaptive Immunity in the Development of Theiler's Virus-Induced Demyelinating Disease.
Kim B
Int J Mol Sci. 2021; 22(10).
PMID: 34067536
PMC: 8156427.
DOI: 10.3390/ijms22105254.
Viral mouse models used to study multiple sclerosis: past and present.
Libbey J, Fujinami R
Arch Virol. 2021; 166(4):1015-1033.
PMID: 33582855
PMC: 7882042.
DOI: 10.1007/s00705-021-04968-5.
Facets of Theiler's Murine Encephalomyelitis Virus-Induced Diseases: An Update.
Gerhauser I, Hansmann F, Ciurkiewicz M, Loscher W, Beineke A
Int J Mol Sci. 2019; 20(2).
PMID: 30669615
PMC: 6358740.
DOI: 10.3390/ijms20020448.
Monocytes and Macrophages as Viral Targets and Reservoirs.
Nikitina E, Larionova I, Choinzonov E, Kzhyshkowska J
Int J Mol Sci. 2018; 19(9).
PMID: 30231586
PMC: 6163364.
DOI: 10.3390/ijms19092821.
Traditional Uses of Cannabinoids and New Perspectives in the Treatment of Multiple Sclerosis.
Gado F, Digiacomo M, Macchia M, Bertini S, Manera C
Medicines (Basel). 2018; 5(3).
PMID: 30111755
PMC: 6164967.
DOI: 10.3390/medicines5030091.
The influence of macrophage growth factors on Theiler's Murine Encephalomyelitis Virus (TMEV) infection and activation of macrophages.
Schneider K, Watson N, Minchenberg S, Massa P
Cytokine. 2017; 102:83-93.
PMID: 28800924
PMC: 5803477.
DOI: 10.1016/j.cyto.2017.07.015.
Theiler's murine encephalomyelitis virus infection of SJL/J and C57BL/6J mice: Models for multiple sclerosis and epilepsy.
DePaula-Silva A, Hanak T, Libbey J, Fujinami R
J Neuroimmunol. 2017; 308:30-42.
PMID: 28237622
PMC: 5474355.
DOI: 10.1016/j.jneuroim.2017.02.012.
Macrophages and the Viral Dissemination Super Highway.
Klepper A, Branch A
EC Microbiol. 2016; 2(3):328-336.
PMID: 26949751
PMC: 4774560.
Close Encounters of the First Kind: Innate Sensors and Multiple Sclerosis.
Fernandez-Paredes L, de Diego R, de Andres C, Sanchez-Ramon S
Mol Neurobiol. 2016; 54(1):101-114.
PMID: 26732593
DOI: 10.1007/s12035-015-9665-5.
Depletion of Olig2 in oligodendrocyte progenitor cells infected by Theiler's murine encephalomyelitis virus.
Benner B, Martorell A, Mahadevan P, Najm F, Tesar P, Freundt E
J Neurovirol. 2015; 22(3):336-48.
PMID: 26631080
DOI: 10.1007/s13365-015-0402-7.
Self-reactive CD4(+) T cells activated during viral-induced demyelination do not prevent clinical recovery.
Savarin C, Bergmann C, Gaignage M, Stohlman S
J Neuroinflammation. 2015; 12:207.
PMID: 26559484
PMC: 4642610.
DOI: 10.1186/s12974-015-0426-1.
Modeling the acute and chronic phases of Theiler murine encephalomyelitis virus infection.
Zhang J, Lipton H, Perelson A, Dahari H
J Virol. 2013; 87(7):4052-9.
PMID: 23365440
PMC: 3624189.
DOI: 10.1128/JVI.03395-12.
Inflammatory monocytes and the pathogenesis of viral encephalitis.
Terry R, Getts D, Deffrasnes C, van Vreden C, Campbell I, King N
J Neuroinflammation. 2012; 9:270.
PMID: 23244217
PMC: 3560265.
DOI: 10.1186/1742-2094-9-270.
Viral models of multiple sclerosis: neurodegeneration and demyelination in mice infected with Theiler's virus.
Mecha M, Carrillo-Salinas F, Mestre L, Feliu A, Guaza C
Prog Neurobiol. 2012; 101-102:46-64.
PMID: 23201558
PMC: 7117056.
DOI: 10.1016/j.pneurobio.2012.11.003.
Chronic social stress impairs virus specific adaptive immunity during acute Theiler's virus infection.
Young E, Vichaya E, Reusser N, Cook J, Steelman A, Welsh C
J Neuroimmunol. 2012; 254(1-2):19-27.
PMID: 23021485
PMC: 4464662.
DOI: 10.1016/j.jneuroim.2012.08.014.